CV Sciences, Inc. Reports First Quarter 2022 Financial Results
16 mai 2022 09h00 HE
|
CV Sciences, Inc.
SAN DIEGO, May 16, 2022 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent supplier and manufacturer of hemp cannabidiol (CBD)...
CV Sciences, Inc. to Announce First Quarter 2022 Results On May 16, 2022
12 mai 2022 07h00 HE
|
CV Sciences, Inc.
SAN DIEGO, May 12, 2022 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent supplier and manufacturer of hemp cannabidiol (CBD)...
CV Sciences, Inc. Reports Fiscal Year-End 2021 Financial Results
31 mars 2022 16h05 HE
|
CV Sciences, Inc.
SAN DIEGO, March 31, 2022 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent supplier and manufacturer of hemp cannabidiol (CBD)...
CV Sciences, Inc. to Announce Fourth Quarter and Full Year 2021 Results on March 31, 2022
28 mars 2022 16h05 HE
|
CV Sciences, Inc.
SAN DIEGO, March 28, 2022 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent supplier and manufacturer of hemp cannabidiol (CBD)...
UPDATE -- CV Sciences Adds +PlusCBD Relief Softgels to Wellness Line of CBD Products
11 mars 2022 12h59 HE
|
CV Sciences, Inc.
SAN DIEGO, March 11, 2022 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent supplier and manufacturer of hemp cannabidiol (CBD)...
CV Sciences Adds +PlusCBD Relief Softgels to Wellness Line of CBD Products
08 mars 2022 09h11 HE
|
CV Sciences, Inc.
SAN DIEGO, March 08, 2022 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent supplier and manufacturer of hemp cannabidiol (CBD)...
CV Sciences, Inc. Announces Launch of +PlusCBD™ Pain Relief Topicals
11 janv. 2022 08h00 HE
|
CV Sciences, Inc.
SAN DIEGO, Jan. 11, 2022 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent supplier and manufacturer of hemp cannabidiol (“CBD”)...
CV Sciences, Inc. Announces New Distribution Agreement with GNC
05 janv. 2022 08h00 HE
|
CV Sciences, Inc.
SAN DIEGO, Jan. 05, 2022 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB: CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent supplier and manufacturer of hemp cannabidiol (CBD)...
CV Sciences, Inc. Appoints Haskell & White LLP as Auditor
30 nov. 2021 16h30 HE
|
CV Sciences, Inc.
SAN DIEGO, Nov. 30, 2021 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent supplier and manufacturer of hemp cannabidiol (CBD)...
CV Sciences, Inc. Announces Convertible Note Financing
15 nov. 2021 08h25 HE
|
CV Sciences, Inc.
SAN DIEGO, Nov. 15, 2021 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent supplier and manufacturer of hemp cannabidiol (CBD)...